317 related articles for article (PubMed ID: 17643117)
1. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
Zippo A; De Robertis A; Serafini R; Oliviero S
Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
[TBL] [Abstract][Full Text] [Related]
2. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
3. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
Bouquet C; Melchers F
Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
[TBL] [Abstract][Full Text] [Related]
4. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.
Frank SR; Schroeder M; Fernandez P; Taubert S; Amati B
Genes Dev; 2001 Aug; 15(16):2069-82. PubMed ID: 11511539
[TBL] [Abstract][Full Text] [Related]
5. Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation.
Mochizuki T; Kitanaka C; Noguchi K; Sugiyama A; Kagaya S; Chi S; Asai A; Kuchino Y
Oncogene; 1997 Sep; 15(12):1471-80. PubMed ID: 9333023
[TBL] [Abstract][Full Text] [Related]
6. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
[TBL] [Abstract][Full Text] [Related]
7. In vivo GSH depletion induces c-myc expression by modulation of chromatin protein complexes.
Torres L; Sandoval J; Penella E; Zaragozá R; García C; Rodríguez JL; Viña JR; García-Trevijano ER
Free Radic Biol Med; 2009 Jun; 46(11):1534-42. PubMed ID: 19289167
[TBL] [Abstract][Full Text] [Related]
8. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
[TBL] [Abstract][Full Text] [Related]
9. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
Zhang Y; Sif S; DeWille J
J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
[TBL] [Abstract][Full Text] [Related]
10. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
[TBL] [Abstract][Full Text] [Related]
11. [The Pim family of protein kinases: structure, functions and roles in hematopoietic malignancies].
Zhukova IuN; Alekseeva MG; Zakharevich NV; Shtil' AA; Danilenko VN
Mol Biol (Mosk); 2011; 45(5):755-64. PubMed ID: 22393773
[TBL] [Abstract][Full Text] [Related]
12. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
[TBL] [Abstract][Full Text] [Related]
13. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis.
Park J; Kunjibettu S; McMahon SB; Cole MD
Genes Dev; 2001 Jul; 15(13):1619-24. PubMed ID: 11445536
[TBL] [Abstract][Full Text] [Related]
14. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
Feng Y; Lee N; Fearon ER
Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
[TBL] [Abstract][Full Text] [Related]
15. Identification of AKT-regulated genes in inducible MERAkt cells.
Kuhn I; Bartholdi MF; Salamon H; Feldman RI; Roth RA; Johnson PH
Physiol Genomics; 2001 Dec; 7(2):105-14. PubMed ID: 11773597
[TBL] [Abstract][Full Text] [Related]
16. Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.
Kreuz S; Holmes KB; Tooze RM; Lefevre PF
Mol Cancer; 2015 Dec; 14():205. PubMed ID: 26643319
[TBL] [Abstract][Full Text] [Related]
17. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
[TBL] [Abstract][Full Text] [Related]
18. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of c-Myc and cell immortalization alters c-Myc phosphorylation.
Lutterbach B; Hann SR
Oncogene; 1997 Feb; 14(8):967-75. PubMed ID: 9050996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]